Denemek ALTIN - Özgür
Deepfakes, voice clones: Celebrities fight AI threat
Mint Mumbai
|October 01, 2025
Experts say India's legal framework is inadequate to stop the complexity of AI infringements
AI tools can generate highly convincing deepfake videos and voice clones, making it difficult to trace and remove them, especially across multiple platforms.
(ISTOCKPHOTO)
While the likes of Aishwarya Rai Bachchan, Abhishek Bachchan and Karan Johar move court to protect their personality rights-including their name, image and signature-experts say artificial intelligence (AI) is making it increasingly difficult to detect and prevent such violations.
AI tools can generate highly convincing deepfake videos and voice clones, making it difficult to trace and remove them, especially across multiple platforms. Personality rights violations hurt celebrities not just financially but also in terms of brand equity. Fake endorsements and unauthorized merchandise can wipe out licensing fees and royalties worth crores. The counterfeit goods market is estimated to be ₹40,000 crore.
The reputational damage can be even more severe. Pornographic deepfakes or morphed content inflict irreparable harm, erode brand exclusivity and can slash future endorsement fees by 20-30%. Top Bollywood actors charge anywhere from ₹5 crore to ₹10 crore per endorsement.
Bu hikaye Mint Mumbai dergisinin October 01, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Mumbai'den DAHA FAZLA HİKAYE
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size
